Clinical Development Services

Human Challenge
Full-service Solution

hVIVO Challenge Models

Laboratory Services

Clinical Scientific Papers / Abstracts

ERS International Congress 2020 Presentation: Experimental Respiratory Syncytial Virus Infection in Adults 60-75 years

Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics

A Key Endpoint in Viral Challenge Models of Asthma Exacerbations

Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model

DEVELOPMENT AND VALIDATION OF AN ALGORITHM PROGNOSTIC FOR INFLUENZA CONTAGIOUSNESS

THE HUMAN VIRAL CHALLENGE MODEL WITH A/PERTH/16/2009 H3N2A SYSTEMATIC ANALYSIS FROM FIVE CLINICAL STUDIES

Scientific Paper 106 – Effect of pre-existing serum and mucosal antibody on experimental respiratory syncytial virus (RSV) challenge and infection of adults

Scientific paper 49 – An oseltamivir treatment-selected influenza A/N2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo

Scientific paper 48 – Influenza virus infection in the second and third trimesters of pregnancy : a clinical and seroepidemiological study

Scientific paper 45 – Targeting influenza virus neuraminidase—a new strategy for antiviral therapy